Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 Feb;31(2):67-71.
doi: 10.1002/clc.20167.

Positive troponin in diabetic ketoacidosis without evident acute coronary syndrome predicts adverse cardiac events

Mouaz Al-Mallah  1 , Omar Zuberi, Muhammad Arida, Henry E Kim
Affiliations

Positive troponin in diabetic ketoacidosis without evident acute coronary syndrome predicts adverse cardiac events

Mouaz Al-Mallah et al. Clin Cardiol. 2008 Feb.

Abstract

Background: Elevated troponin I has been associated with increased mortality in critically ill patients without acute coronary syndrome (ACS). However, the prognostic significance of troponin elevation in patients with diabetic ketoacidosis (DKA) without evident ACS has not been studied.

Methods: Retrospective study of all patients admitted to a U.S. tertiary center between 01/98 and 12/00 with DKA and had troponin I level measured. Patients with evidence of ACS or who met the American College of Cardiology/European Society of Cardiology (ACC/ESC) definition for myocardial infarction were excluded. Baseline characteristics, cardiac evaluation and 2 year major adverse coronary event (MACE) rate were compared between patients with positive and negative troponin.

Results: Ninety-six patients fulfilled the inclusion criteria of this study, 26 had positive troponin. There were no differences in baseline characteristics between the two groups. After a 2 year follow-up, there was significantly increased mortality in patients with elevated troponin (50.0% versus 27.1%, hazard-ratio (HR) 2.3, 95% confidence interval (CI) 1.2-4.8, p = 0.02). Patients with elevated troponin also had significantly increased MACE rate at 2 years (50.0% versus 28.6%, HR 2.6, 95% CI 1.3-5.3, p = 0.007) driven primarily by mortality. Using Cox Proportional Hazard Analysis, elevated troponin was a predictor of increased MACE after adjusting for confounding variables. (Adjusted HR 2.3, 95% CI 1.1-4.6, p = 0.02)

Conclusions: Elevated troponin I in diabetic patients admitted with DKA identifies a group at very high risk for future cardiac events and mortality. Whether cardiac risk stratification of these patients will improve long term outcome remains to be studied.

PubMed Disclaimer

References

    1. Delaney MF, Zisman A, Kettyle WM: Diabetic ketoacidosis and hyperglycemic hyperosmolar nonketotic syndrome. Endocrinol Metab Clin North Am 2000; 29: 683–705. - PubMed
    1. Krentz AJ, Natrass M: Acute metabolic complications of diabetes mellitus: diabetic ketoacidosis, hyperosmolar non‐ketotic syndrome and lactic acidosis In Textbook of Diabetes (2nd ed.) (Eds. Pickup JC, Williams G.), pp 1–23. Oxford: Blackwell Sciences, 1997,; 39.
    1. Antman EM, Tanasijevic MJ, Thompson B, Schactman M, McCabe CH, et al.: Cardiac‐specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. N Engl J Med 1996; 335: 1342–1349. - PubMed
    1. Heidenreich PA, Alloggiamento T, Melsop K, McDonald KM, Go AS, et al.: The prognostic value of troponin in patients with non‐ST elevation acute coronary syndromes: a meta‐analysis. J Am Coll Cardiol 2001; 38: 478–485. - PubMed
    1. Morrow DA, Cannon CP, Rifai N, Frey MJ, Vicari R, et al.: Ability of minor elevations of troponins I and T to predict benefit from an early invasive strategy in patients with unstable angina and non‐ST elevation myocardial infarction. JAMA 2001; 286: 2405–2412. - PubMed

MeSH terms